GTF2E2 and pancreatic adenocarcinoma: In the analysis of the PFI across these cancers, GTF2E2 was associated with an increased risk in ACC, LGG, KICH, KIRC, KIRP, LIHC, MESO and PAAD (Fig 5, Fig S3A–S3L).